Clinical trials
Phase 2 Borderline Personality Disorder trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 4 |
| 2007 | 1 |
| 2010 | 3 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 4 |
| Terminated | 4 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Chicago | 4 |
| Yale University | 4 |
| AstraZeneca | 1 |
| Boehringer Ingelheim | 1 |
| Central Institute of Mental Health, Mannheim | 1 |
| Columbia Northwest Pharmaceuticals | 1 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 1 |
| Hannover Medical School | 1 |
| Indiana University | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Borderline Personality Disorder | 25 |
| Major Depressive Disorder | 4 |
| Alcoholism | 1 |
| Bipolar Disorder | 1 |
| Depressive Disorder, Treatment-Resistant | 1 |
| Dissociative Disorders | 1 |
| Dysthymic Disorder | 1 |
| Mental Disorders | 1 |
| Personality Disorders | 1 |
Trials
Showing 51 to 25 of 25. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.